AJANTPHARM

Ajanta Pharma Share Price

 

 

Invest in Ajanta Pharma with 3.39X leverage

Invest with MTF

Performance

  • Low
  • ₹2,614
  • High
  • ₹2,660
  • 52 Week Low
  • ₹2,327
  • 52 Week High
  • ₹3,116
  • Open Price₹2,632
  • Previous Close₹2,629
  • Volume83,802

Investment Returns

  • Over 1 Month + 1.15%
  • Over 3 Month + 1.53%
  • Over 6 Month + 2.1%
  • Over 1 Year -11.68%

Smart Investing Starts Here Start SIP with Ajanta Pharma for Steady Growth!

Invest Now

Ajanta Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 33.9
  • PEG Ratio
  • 3
  • Market Cap Cr
  • 32,984
  • P/B Ratio
  • Average True Range
  • 58.04
  • EPS
  • 77.93
  • Dividend Yield
  • 1.1
  • MACD Signal
  • 20.19
  • RSI
  • 66.96
  • MFI
  • 82.4

Ajanta Pharma Financials

Ajanta Pharma Technicals

EMA & SMA

Current Price
₹2,640.60
+ 12.1 (0.46%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹2,551.91
  • 50 Day
  • ₹2,529.46
  • 100 Day
  • ₹2,547.93
  • 200 Day
  • ₹2,583.86

Resistance and Support

2638 Pivot Speed
  • R3 2,708.60
  • R2 2,684.20
  • R1 2,662.40
  • S1 2,616.20
  • S2 2,591.80
  • S3 2,570.00

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Ajanta Pharma is a specialty pharmaceutical company offering innovative, high-quality medicines across 30+ countries. With leadership in multiple therapeutic segments, Ajanta operates 7 state-of-the-art manufacturing facilities, supported by robust R&D capabilities and a strong global presence.

Ajanta Pharma has an operating revenue of Rs. 4,972.92 Cr. on a trailing 12-month basis. An annual revenue growth of 10% is good, Pre-tax margin of 26% is great, ROE of 24% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its 200DMA and around 5% above its 50DMA. It needs to stay above the 200DMA levels to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 70 which is a FAIR score but needs to improve its earnings, a RS Rating of 60 which is FAIR indicating the recent price performance, Buyer Demand at C+ which is evident from recent supply seen, Group Rank of 41 indicates it belongs to a fair industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Ajanta Pharma Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-03 Quarterly Results & Interim Dividend
2025-07-28 Quarterly Results & Others To consider other business matters. per share(475%)Interim Dividend
2025-04-30 Audited Results & A.G.M.
2025-01-30 Quarterly Results
2024-10-28 Quarterly Results
Date Purpose Remarks
2025-11-10 INTERIM Rs.28.00 per share(1400%)First Interim Dividend
2024-11-06 INTERIM Rs.28.00 per share(1400%)First Interim Dividend
2024-02-08 INTERIM Rs.26.00 per share(1300%)Second Interim Dividend
2023-08-04 SPECIAL Rs.15.00 per share(750%)Special Dividend
2023-08-04 INTERIM Rs.10.00 per share(500%)First Interim Dividend
View Ajanta Pharma Dividend History Arrow
Date Purpose Remarks
2022-06-23 Bonus Rs.0.00 issue in the ratio of 1:2 of Rs. 2/-.

Ajanta Pharma F&O

Ajanta Pharma Shareholding Pattern

66.25%
14.67%
2.64%
8.53%
0%
6.53%
1.38%

About Ajanta Pharma

  • NSE Symbol
  • AJANTPHARM
  • BSE Symbol
  • 532331
  • Managing Director
  • Mr. Yogesh M Agrawal
  • ISIN
  • INE031B01049

Similar Stocks to Ajanta Pharma

Ajanta Pharma FAQs

Ajanta Pharma share price is ₹2,640 As on 06 December, 2025 | 01:08

The Market Cap of Ajanta Pharma is ₹32984.3 Cr As on 06 December, 2025 | 01:08

The P/E ratio of Ajanta Pharma is 33.9 As on 06 December, 2025 | 01:08

The PB ratio of Ajanta Pharma is 9 As on 06 December, 2025 | 01:08

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23